亂中有序
205
ࢨ
bias
dΪ
މ
ʔΝᕙЍٙፃΈdʔΝٙ౺˪ɪЗໄd
ʔΝٙઞ০ண
ࠇ
ே̙ঐிϓࢨdΝࣛɦϞ
౻ߠ
ɪٙᕏৃ
noise
ਪᕚiટഹd͟ྼ᜕܃ίӊɓ˪ਿΪ౺˪ྼ
ყЪɪεˇᐼึʔɓᅵdˢ˙Ⴍ
ה
̋၇ኒඎe
ܓ
ሜ
છe
ݑ
Ѝe
ݹ
ഃdОɓ
ࡈ
ӉேϞ̙ঐˏৎႬࢨdி
ϓ౺˪
ܓڥ
d˪˪ʔΝdவࣛ༈
ܣ
ჿ፫kϤࣛdஷ੬
ࠅ
ீཀ୕
ࠇ
ٙ˙
ج
d̘ਂ੬࿒ʷ
normalization
fШତί
ਪᕚԸədΪ
މ
Ϟʔˇٙ୕
ࠇ
ኪேίਂவԫd ௦ٙ
݊ʔΝٙ˙
ج
dֻֻึிϓʔΝٙഐ
؈
dѢᓔfҢ
ࡁ
ึ
ܔ
ᙄε͜ʔΝ˙
ج
̘Ҭ̈־ϤගٙΝഐ
؈
f̤̮dᒱ
್Ң
ࡁ
ேҎૐٝ༸ӊɓ
ࡈ
ਿΪϞεˇ
ڌ
ତඎdШ݊Ցͦ
ۃ
މ
˟dฆ৬ΐਿΪ౺˪݊ೌ
ج
ᛘ̈աᏨ
mRNA
ٙഒ࿁ў
ඎdତίਬɓঐਂՑٙ݊࿁ඎdఱ݊ਿΪίʔΝա
Ꮸʘග࿁
ڌ
ତඎՑֵ݊εˇdவ݊ˢ༰ঐપП̈
Ըٙf
ߕ
̺
ݾ
ᅃӺ
ה
Br oad I ns t i t u t e o f MIT and
H a r v a r d
d
ܘ
Ϙఱ˸ฆ৬ΐਿΪ౺˪ӺͣАष
leukemia
dଟਿΪ
ڌ
ତඎɪЪкᓙd൙ПவɛՑ
ֵٙ݊ԟɓ၇ᗳۨٙͣАषdவᗳӺʊપᄿՑεश
षfၽɽᔼኪ৫৫
ڗ
เ᧑ϫબ࿁٬ᐖ
Lung cancer
ਂə
ܘ
εٙӺf٬ᐖ̙˸ʱ
މ
ʃ
ߤ
ٙၾ
ڢ
ʃ
ߤ
ٙd್
ᒔϞՉ˼၇ᗳdͦ
ۃ
Ӻ௰ᆠഖٙʱ
ڢމ
ʃ
٬ߤ
ᐖd
เબྠඟί
New England Journal of Medicine
Ϟɓᇐ ¨
A
five-gene signature and clinical outcome in non-small cell lung